AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25901453 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Healthware™ intervention
Number of subjects: 3786
Study 23704198 — intervention group
Group type: EXPERIMENTAL
Intervention: Copenhagen Physical Activity after Cancer Treatment (PACT)
Number of subjects: 214
Study 23704198 — intervention group
Group type: COMPARATOR
Intervention: Health Evaluation Program (HE)
Number of subjects: 214
Study 21339010 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-operative radiation therapy (IORT) combined with surgical resection (n=73)
Number of subjects: 142
Study 21339010 — intervention group
Group type: COMPARATOR
Intervention: Surgical resection alone (Control group: n=69)
Number of subjects: 142
Study 19013603 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg for 1 week run-in and 100 mg for 3 weeks)
Number of subjects: 292
Study 19013603 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 292
Study 17804354 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care (EUC) including routine depression screening and staff training in depression care management
Number of subjects: 311
Study 17804354 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (INT) including antidepressants and/or psychotherapy treatment plus EUC
Number of subjects: 311
Study 15197190 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinblastine, methotrexate with calcium leucovorin rescue, and fluorouracil (VbMF)
Number of subjects: 193
Study 15197190 — intervention group
Group type: COMPARATOR
Intervention: Vincristine, doxorubicin, cyclophosphamide, and prednisone (VACP)
Number of subjects: 193
Study 15197190 — intervention group
Group type: COMPARATOR
Intervention: VACP (additional cycles)
Number of subjects: 193
Study 12022217 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal midazolam (2 mg) with 1.5 ml of 5% lignocaine
Number of subjects: 40
Study 12022217 — intervention group
Group type: COMPARATOR
Intervention: 1.5 ml of 5% lignocaine only
Number of subjects: 40
Study 9520891 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine
Number of subjects: 19
Study 9520891 — intervention group
Group type: COMPARATOR
Intervention: saline (placebo)
Number of subjects: 19
Study 8013688 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous mononuclear cells (MNC)
Number of subjects: 33
Study 8013688 — intervention group
Group type: COMPARATOR
Intervention: Tissue culture medium alone (Control)
Number of subjects: 33
Study 2492235 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicle-stimulating hormone (FSH) administered at different times during the menstrual cycle
Number of subjects: 67
Study 2492235 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate, 100 mg/day for days 2 to 6; FSH, 150 units/day for days 1 to 4; human menopausal gonadotropin, 150 units/day from day 5 until hCG administration
Number of subjects: 67
Study 4618908 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled trials of treatment for liver disease in children
Number of subjects: 0
Study 4618908 — intervention group
Group type: COMPARATOR
Intervention: Controlled trials
Number of subjects: 0
Study 31654838 — intervention group
Group type: EXPERIMENTAL
Intervention: Alectinib 600 mg
Number of subjects: 197
Study 31654838 — intervention group
Group type: COMPARATOR
Intervention: Crizotinib 250 mg
Number of subjects: 197
Study 27717996 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg doxazosin
Number of subjects: 66
Study 27717996 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg doxazosin
Number of subjects: 66
Study 27717996 — intervention group
Group type: COMPARATOR
Intervention: Control group (hydration and analgesics only)
Number of subjects: 66
Study 26234955 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer Network Counseling intervention
Number of subjects: 119
Study 26234955 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 119
Study 23941542 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal dexamethasone implant
Number of subjects: 20
Study 23941542 — intervention group
Group type: COMPARATOR
Intervention: Oral steroids
Number of subjects: 20
Study 21306624 — intervention group
Group type: EXPERIMENTAL
Intervention: Manualized 12-week CBT intervention for anger delivered by trained day-service staff
Number of subjects: 0
Study 21306624 — intervention group
Group type: COMPARATOR
Intervention: Support as usual waiting-list control group
Number of subjects: 0
Study 19209072 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 0
Study 19209072 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance cycling
Number of subjects: 0
Study 19209072 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 16897286 — intervention group
Group type: EXPERIMENTAL
Intervention: Tannenbaum stent (n = 24)
Number of subjects: 47
Study 16897286 — intervention group
Group type: COMPARATOR
Intervention: Uncovered self-expandable metal stent (n = 23)
Number of subjects: 47
Study 16113424 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with budesonide and formoterol
Number of subjects: 0
Study 16113424 — intervention group
Group type: COMPARATOR
Intervention: Combination therapy with inhaled corticosteroids and long-acting beta-agonists
Number of subjects: 0
Study 16113424 — intervention group
Group type: COMPARATOR
Intervention: Inhaled corticosteroids
Number of subjects: 0
Study 16113424 — intervention group
Group type: COMPARATOR
Intervention: Inhaled bronchodilators (tiotropium)
Number of subjects: 0
Study 16113424 — intervention group
Group type: COMPARATOR
Intervention: Pulmonary rehabilitation
Number of subjects: 0
Study 11780699 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 0
Study 11780699 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 0
Study 11780699 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel chemotherapy and new biologic agents
Number of subjects: 0
Study 9623560 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse calcitriol (3.0 microg twice a week)
Number of subjects: 18
Study 9623560 — intervention group
Group type: COMPARATOR
Intervention: Daily calcitriol (0.75 microg a day)
Number of subjects: 18
Study 9623560 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (pulse and daily calcitriol)
Number of subjects: 18
Study 7843579 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (0.125 mg, with option to increase to 0.25 mg)
Number of subjects: 100
Study 7843579 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 3281016 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention focusing on diet, physical activity, and cigarette smoking.
Number of subjects: 1769
Study 29779884 — intervention group
Group type: EXPERIMENTAL
Intervention: SMASH-U classification system
Number of subjects: 156
Study 29779884 — intervention group
Group type: COMPARATOR
Intervention: H-ATOMIC classification system
Number of subjects: 156
Study 27177525 — intervention group
Group type: EXPERIMENTAL
Intervention: Last exposure to magnesium <12 hours prior to delivery
Number of subjects: 906
Study 27177525 — intervention group
Group type: COMPARATOR
Intervention: Last exposure to magnesium ≥12 hours prior to delivery
Number of subjects: 906
Study 27177525 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary outcomes (moderate/severe cerebral palsy and moderate/severe cerebral palsy or death)
Number of subjects: 906
Study 24114891 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment manoeuvre (RM) after suctioning
Number of subjects: 54
Study 24114891 — intervention group
Group type: COMPARATOR
Intervention: No recruitment manoeuvre (NRM)
Number of subjects: 54
Study 22085043 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbicide research involvement
Number of subjects: 28
Study 22085043 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial participation disclosure
Number of subjects: 28
Study 21186536 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐interferon alpha‐2a (PEG‐IFNalpha‐2a)
Number of subjects: 81
Study 21186536 — intervention group
Group type: COMPARATOR
Intervention: Adefovir dipivoxil (ADV)
Number of subjects: 81
Study 18703440 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined pharmacologic and behavioral smoking cessation intervention (10-week group intervention + nicotine replacement therapy)
Number of subjects: 250
Study 18703440 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 250
Study 15989013 — intervention group
Group type: EXPERIMENTAL
Intervention: noliprel (2 mg/0.625 mg)
Number of subjects: 40
Study 15989013 — intervention group
Group type: COMPARATOR
Intervention: caposide (50 mg/25 mg)
Number of subjects: 40
Study 12028720 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Environment (VE) condition
Number of subjects: 30
Study 12028720 — intervention group
Group type: EXPERIMENTAL
Intervention: VE 2(1/2)-D task
Number of subjects: 30
Study 12028720 — intervention group
Group type: EXPERIMENTAL
Intervention: VE 2(1/2)-D with added background
Number of subjects: 30
Study 12028720 — intervention group
Group type: COMPARATOR
Intervention: Real World (RW) task
Number of subjects: 30
Study 10520389 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexamethasone
Number of subjects: 41
Study 10520389 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 7486272 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin (APR)
Number of subjects: 104
Study 7486272 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TRA)
Number of subjects: 104
Study 7486272 — intervention group
Group type: COMPARATOR
Intervention: Control group (CTR)
Number of subjects: 104
Study 2326520 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss of resistance technique (Group I, n = 35)
Number of subjects: 71
Study 2326520 — intervention group
Group type: COMPARATOR
Intervention: Episensor technique (Group II)
Number of subjects: 71
Study 7000589 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromium-rich brewers' yeast (9 g daily for 8 weeks)
Number of subjects: 24
Study 7000589 — intervention group
Group type: COMPARATOR
Intervention: Chromium-poor torula yeast (control)
Number of subjects: 24
Study 31252146 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole gel-flakes (50 mg/daily for three days)
Number of subjects: 0
Study 31252146 — intervention group
Group type: COMPARATOR
Intervention: Gynoconazol vaginal cream (80 mg terconazole/daily for three days)
Number of subjects: 0
Study 29246139 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational Program (EG)
Number of subjects: 122
Study 29246139 — intervention group
Group type: COMPARATOR
Intervention: Usual care (CG)
Number of subjects: 122
Study 27324431 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group rated 'a little worse' on the Clinicians' Global Impression of Change Scale
Number of subjects: 0
Study 27324431 — intervention group
Group type: COMPARATOR
Intervention: Control group rated 'unchanged' on the Clinicians' Global Impression of Change Scale
Number of subjects: 0
Study 27324431 — intervention group
Group type: EXPERIMENTAL
Intervention: Activities of daily living
Number of subjects: 0
Study 25591635 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy including reflex action and tizanidine
Number of subjects: 248
Study 25591635 — intervention group
Group type: COMPARATOR
Intervention: Standard methods (reflex therapy of СЕЕР and local injections of a combination of local anesthetics with small doses of steroids)
Number of subjects: 248
Study 22456862 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy drink containing 80 mg of caffeine plus alcohol (0.046 and 0.087% breathalyser alcohol concentration)
Number of subjects: 20
Study 22456862 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink plus alcohol (0.046 and 0.087% breathalyser alcohol concentration)
Number of subjects: 20
Study 22456862 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy drink plus alcohol
Number of subjects: 20
Study 22456862 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus alcohol
Number of subjects: 20
Study 20380913 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose cannabis (19 mg delta‐9‐THC)
Number of subjects: 47
Study 20380913 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose cannabis
Number of subjects: 47
Study 20380913 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.4g/kg and 0.6g/kg)
Number of subjects: 47
Study 20380913 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0g/kg alcohol)
Number of subjects: 47
Study 20380913 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of high dose cannabis and alcohol
Number of subjects: 47
Study 18794019 — intervention group
Group type: EXPERIMENTAL
Intervention: Japanese-style acupuncture (n=9)
Number of subjects: 18
Study 18794019 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture control (n=5)
Number of subjects: 18
Study 15699056 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief psychosocial intervention (Dutch version of W. R. Millers' Drinker's Check‐Up), n = 61
Number of subjects: 123
Study 15699056 — intervention group
Group type: COMPARATOR
Intervention: Care as usual, n = 62
Number of subjects: 123
Study 12711931 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.5 g/kg, 10% w/v)
Number of subjects: 13
Study 12711931 — intervention group
Group type: COMPARATOR
Intervention: 4‐methylpyrazole (10‐15 mg/kg orally)
Number of subjects: 13
Study 10575581 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 2 embryo transfer
Number of subjects: 0
Study 10575581 — intervention group
Group type: COMPARATOR
Intervention: Day 3 embryo transfer
Number of subjects: 0
Study 8739611 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol 0.55 g/kg
Number of subjects: 9
Study 8739611 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol 0.85 g/kg
Number of subjects: 9
Study 8739611 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 9377589 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphatidylcholine (PCh) 25 g
Number of subjects: 80
Study 9377589 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphatidylcholine (PCh) 10 g
Number of subjects: 80
Study 9377589 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 3469962 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory resistive training for six weeks
Number of subjects: 18
Study 3469962 — intervention group
Group type: COMPARATOR
Intervention: Placebo device
Number of subjects: 18
Study 31124194 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK2981710 (30 g/day)
Number of subjects: 80
Study 31124194 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 29483060 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide 1.5 mg
Number of subjects: 424
Study 29483060 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide 0.75 mg
Number of subjects: 424
Study 29483060 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 424
Study 27383499 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (4μg/mL) with 2mL load, 1.5ml background infusion, 0.5mL single dose, 20s locking time
Number of subjects: 150
Study 27383499 — intervention group
Group type: COMPARATOR
Intervention: Normal saline at 10ml/h
Number of subjects: 150
Study 27383499 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (4μg/mL)
Number of subjects: 150
Study 25610500 — intervention group
Group type: EXPERIMENTAL
Intervention: FLU/FOR
Number of subjects: 243
Study 25610500 — intervention group
Group type: COMPARATOR
Intervention: BUD/FOR
Number of subjects: 243
Study 25610500 — intervention group
Group type: COMPARATOR
Intervention: FLU
Number of subjects: 243
Study 24681810 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR (400-800 mg/day)
Number of subjects: 216
Study 24681810 — intervention group
Group type: COMPARATOR
Intervention: Risperidone (4-6 mg/day)
Number of subjects: 216
Study 21749166 — intervention group
Group type: EXPERIMENTAL
Intervention: DFDBA
Number of subjects: 40
Study 21749166 — intervention group
Group type: COMPARATOR
Intervention: FDBA
Number of subjects: 40
Study 19645754 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyl mercury intake from fish consumption
Number of subjects: 0
Study 19645754 — intervention group
Group type: EXPERIMENTAL
Intervention: Hair mercury levels
Number of subjects: 0
Study 19645754 — intervention group
Group type: COMPARATOR
Intervention: Comparison with survey data
Number of subjects: 0
Study 17578722 — intervention group
Group type: EXPERIMENTAL
Intervention: E2 (Estrofem, Novo Nordisk, Copenhagen, Denmark) 2 mg/d given orally over 3 months
Number of subjects: 14
Study 17578722 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 15176764 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy (CRT) (n = 18)
Number of subjects: 63
Study 15176764 — intervention group
Group type: COMPARATOR
Intervention: Control therapy (occupational therapy activities) (n = 14)
Number of subjects: 63
Study 15176764 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (n = 19)
Number of subjects: 63
Study 15176764 — intervention group
Group type: COMPARATOR
Intervention: All treatment types
Number of subjects: 63
Study 12490825 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine therapy
Number of subjects: 0
Study 12490825 — intervention group
Group type: COMPARATOR
Intervention: Other antidepressants (including tricyclic antidepressants and selective serotonin reuptake inhibitors)
Number of subjects: 0
Study 11475716 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated traditional Chinese and Western Medicine (TCM‐WM)
Number of subjects: 155
Study 11475716 — intervention group
Group type: COMPARATOR
Intervention: Western medicine alone (Control)
Number of subjects: 155
Study 8944199 — intervention group
Group type: EXPERIMENTAL
Intervention: Single staircase procedure
Number of subjects: 0
Study 8944199 — intervention group
Group type: COMPARATOR
Intervention: Adaptive probit estimation
Number of subjects: 0
Study 8944199 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 0
Study 1842458 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of low‐molecular dextran or low‐molecular hydroxyethyl starch and hyperbaric oxygenation
Number of subjects: 500
Study 1842458 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygenation (100% oxygen at 2.5 bar)
Number of subjects: 500
Study 6889714 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide plus cisplatin (combination chemotherapy)
Number of subjects: 42
Study 6889714 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide (single-agent chemotherapy)
Number of subjects: 42
Study 30887050 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin with albumin
Number of subjects: 184
Study 30887050 — intervention group
Group type: COMPARATOR
Intervention: Placebo with albumin
Number of subjects: 184
Study 30616685 — intervention group
Group type: EXPERIMENTAL
Intervention: Walkbot‐S™ RAGT group
Number of subjects: 44
Study 30616685 — intervention group
Group type: COMPARATOR
Intervention: Treadmill training group
Number of subjects: 44
Study 28139349 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozanezumab (15 mg/kg)
Number of subjects: 307
Study 28139349 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 307
Study 28139349 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozanezumab
Number of subjects: 307
Study 25613751 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral formula with prebiotics (lactic acid bacteria‐fermented milk products, galacto‐oligosaccharide, bifidogenic growth stimulator)
Number of subjects: 0
Study 25613751 — intervention group
Group type: COMPARATOR
Intervention: Standard formula without prebiotics
Number of subjects: 0
Study 24918330 — intervention group
Group type: EXPERIMENTAL
Intervention: Subparaneural injection of 0.3 mL/kg mepivacaine 10 mg/mL
Number of subjects: 48
Study 24918330 — intervention group
Group type: COMPARATOR
Intervention: Circumferential extraneural injection of 0.3 mL/kg mepivacaine 10 mg/mL
Number of subjects: 48
Study 24918330 — intervention group
Group type: EXPERIMENTAL
Intervention: Unintentional intraepineural injection
Number of subjects: 48
Study 23087262 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasogastric tube feeding
Number of subjects: 20
Study 23087262 — intervention group
Group type: COMPARATOR
Intervention: Postpyloric tube feeding
Number of subjects: 20
Study 23087262 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study 19885874 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 106
Study 19885874 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 106
Study 18097861 — intervention group
Group type: EXPERIMENTAL
Intervention: House dust mite impermeable covers (HDM covers) for pillows, duvets, and mattresses
Number of subjects: 0
Study 18097861 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15334437 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback-assisted cognitive-behavioral treatment (BF/CBT)
Number of subjects: 92
Study 11322865 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional drugs in different combinations
Number of subjects: 0
Study 11322865 — intervention group
Group type: EXPERIMENTAL
Intervention: New treatment approaches for refractory cGvHD
Number of subjects: 0
Study 11322865 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical trials for new approaches
Number of subjects: 0
Study 9853887 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate treatment (1 mg/kg injected transvaginally or intramuscularly)
Number of subjects: 100
Study 9853887 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic salpingotomy
Number of subjects: 100
Study 8011799 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX) 0.5 mg
Number of subjects: 30
Study 8011799 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 8011799 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX) 0.25, 0.5, and 1.0 mg
Number of subjects: 30
Study 1678691 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribavirin
Number of subjects: 287
Study 1678691 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 287